Clinical trials in Grenoble – page 54

654 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FranceEssaisCliniques.fr

Grenoble at a glance

654

clinical trials

Research sites0

Quick filters

654 trials in Grenoble

Open in trial search

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lenalidomide
Sponsor:BeOne Medicines AG

Contact Research Centre

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Nivolumab
Sponsor:Bristol Myers Squibb International Corporation

Contact Research Centre

Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Centre Hospitalier Universitaire De Dijon

Contact Research Centre

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Not recruiting

Registered drugNo placebo

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oseltamivir
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Secondary progressive multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Azathioprine
Sponsor:Centre Hospitalier Universitaire De Rennes

Contact Research Centre

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Unicancer

Contact Research Centre

Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate
Sponsor:Centre Hospitalier Universitaire De Limoges

Contact Research Centre

Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Mps-102
Sponsor:Arcagy Gineco

Contact Research Centre

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nivolumab
Sponsor:Aveo Pharmaceuticals Inc.

Contact Research Centre

Study of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cedazuridine
Sponsor:Groupe Francophone Des Myelodysplasies

Contact Research Centre

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug

France

Participants:18–64 years
Substances:Colestyramine
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Grenoble

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.

Advanced NSCLC Treatment Studies
Gastric Cancer Immunotherapy
Hematologic Malignancies

Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.

02 Transplant Medicine

Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.

Antibody-Mediated Rejection
Novel Immunosuppression Strategies
Long-term Graft Survival

Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.

03 Neurological Disorders

Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.

Sleep Disorder Management
MS Treatment Innovations
Neurological Disease Progression

Cutting-edge treatments being developed to address both rare and common neurological conditions.

Back to France All countries

Clinical trials in Grenoble – page 54

654 trials in Grenoble

Marginal zone lymphoma+1

Study Comparing Zanubrutinib, Obinutuzumab, and Rituximab with Lenalidomide and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Hodgkin's disease

Study of Relatlimab and Nivolumab for Children and Young Adults with Recurrent or Refractory Hodgkin and Non-Hodgkin Lymphoma

Giant cell arteritis

Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Secondary progressive multiple sclerosis

Study on Stopping Disease-Modifying Therapies in Inactive Secondary Progressive Multiple Sclerosis Patients Over 50 Using Glatiramer Acetate and Drug Combination

Colon cancer

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Sepsis

Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

Ovarian cancer+1

Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

Transplant rejection

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Renal cell carcinoma

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Acute myeloid leukaemia+1

Study of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant

Multiple sclerosis

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Filter the trials

Other cities in France

Clinical research in Grenoble

Prefer not to search? Our Concierge searches the trials for you.

Clinical trials in Grenoble – page 54

654 trials in Grenoble

Marginal zone lymphoma+1

Ovarian cancer+1

Acute myeloid leukaemia+1

Other cities in France

Related

Clinical research in Grenoble

Prefer not to search? Our Concierge searches the trials for you.